Joint Venture Between Sanofi Pasteur (SASY.PA), Thailand's Government Pharmaceutical Organization (GPO) Aims for New Vaccine With Fewer Side Effects
11/4/2013 7:51:48 AM
A joint venture between Thailand's Government Pharmaceutical Organization (GPO) and France's Sanofi Pasteur is embarking upon a 700-million-baht upgrade to its vaccine production facility here. The expansion at Government Pharmaceutical Organization-Merieux Biological Products Co (GPO-MBP), to begin this year, will take eight years and result in a new combination vaccine with fewer side effects.
Help employers find you! Check out all the jobs and post your resume.
comments powered by